Your browser doesn't support javascript.
loading
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer.
Edelman, Martin J; Dvorkin, Mikhail; Laktionov, Konstatin; Navarro, Alejandro; Juan-Vidal, Oscar; Kozlov, Vadim; Golden, Gil; Jordan, Odette; Deng, C Q; Bentsion, Dmitriy; Chouaid, Christos; Dechev, Hristo; Dowlati, Afshin; Fernández Núñez, Natalia; Ivashchuk, Olexandr; Kiladze, Ivane; Kortua, Tsira; Leighl, Natasha; Luft, Aleksandr; Makharadze, Tamta; Min, YoungJoo; Quantin, Xavier.
Afiliación
  • Edelman MJ; Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address: martin.edelman@fccc.edu.
  • Dvorkin M; State Budgetary Healthcare Institution of Omsk Region, Omsk, Russia.
  • Laktionov K; Federal State Budgetary Scientific Institution, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.
  • Navarro A; Hospital Universitari Vall d́Hebron, Barcelona, Spain.
  • Juan-Vidal O; Hospital Universitari I Politécnic La Fe, València, Spain.
  • Kozlov V; State Budgetary Healthcare Institution of Novosibirsk Region, Novosibirsk, Russia.
  • Golden G; United Therapeutics Corporation, Durham, NC, USA.
  • Jordan O; United Therapeutics Corporation, Durham, NC, USA.
  • Deng CQ; United Therapeutics Corporation, Durham, NC, USA.
  • Bentsion D; State Budgetary Healthcare Institution, Sverdlovsk Regional Oncology Dispensary, Ekaterinburg, Russia.
  • Chouaid C; Centre Hospitalier Intercommunal Créteil, Créteil, France.
  • Dechev H; Complex Oncology Center - Burgas EOOD, Burgas, Bulgaria.
  • Dowlati A; University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Fernández Núñez N; Hospital Universitario Lucus Augusti, Lugo, Spain.
  • Ivashchuk O; Municipal Institution, Chernivtsi Regional Clinical Oncology Dispensary, State Higher Educational Establishment of Ukraine, Bukovinian State Medical University, Chernivtsi, Ukraine.
  • Kiladze I; LTD Accad. F. Todua Medical Center, Research Institute of Clinical Medicine, Tbilisi, Georgia.
  • Kortua T; Multiprofile Clinic Consilium Medulla, Tbilisi, Georgia.
  • Leighl N; Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Luft A; State Budgetary Healthcare Institution, Leningrad Regional Clinical Hospital, Saint-Petersburg, Russia.
  • Makharadze T; Cancer Center of Adjara Autonomous Republic, Batumi, Georgia.
  • Min Y; Ulsan University Hospital, Ulsan, Korea.
  • Quantin X; Institut du Cancer de Montpellier, Montpellier, France.
Lung Cancer ; 166: 135-142, 2022 04.
Article en En | MEDLINE | ID: mdl-35278766
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda